Pathologies and Treatments

Corneal Dystrophies and Degenerations

distrofies corneals

In most dystrophies and corneal degenerations, changes in corneal transparency are detected, caused by the formation of deposits of abnormal materials. In some cases, when the cornea is more affected in terms of curvature and corneal thickness, ectasias such as keratoconus occur.

The incidence of these diseases is generally low, although there are exceptions, such as epithelial basement membrane dystrophy or guttata cornea (Fuchs’ dystrophy). Their impact is very variable: from going completely unnoticed to causing severe vision loss and, in some cases, requiring a corneal transplant.

FUCHS’ DYSTROPHY
The human cornea is the first lens of the ocular optical system. It is a tissue of about 550 microns, made up of five layers. The last layer of the cornea is the endothelium, formed by a single layer of hexagonal cells that have almost no capacity for regeneration. Endothelial cells are responsible for maintaining corneal transparency.

Fuchs’ dystrophy is one of the main diseases that affect the corneal endothelium.

Symptoms

In this disease, degenerative changes appear in the endothelial cells that lead to premature aging and deterioration of their function, which, in advanced stages, cause corneal thickening, edema, and loss of corneal transparency, especially in the early morning.

Treatments

If vision is significantly compromised, the only solution is corneal transplantation, which is currently performed selectively through a posterior lamellar transplant (DMEK), in which healthy endothelium is transplanted with the aim that the new transplanted endothelial cells restore corneal transparency and, therefore, good vision to the patient.

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Procedures

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Dra. Paula Verdaguer,

MD, PhD

Número de Col·legiat COMB: 40737

Ophthalmologist. Specialist in Cornea, Refractive Surgery, and Cataracts

If you found this interesting, feel free to share it here:

Last modified: 28/08/2025
Scroll to Top
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.